ABBOTT PARK, Ill., June 14, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) ...
International Journal of Pharmceutics: In Vitro: The dissolution characteristics of five capsules (Next Generation Enteric [NGE], Vcaps® Enteric [VCE], VCE DUOCAP® [VCE/VCE] system, Hard Gelatin ...
CREON (Lipase, amylase, protease) e-c minimicrospheres in capsules by AbbVie Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a "zero-overfill" pancreatic ...
Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic fibrosis
CREON (Lipase, amylase, protease) e-c minimicrospheres in capsules by AbbVie Creon (pancrelipase, from Solvay Pharmaceuticals) delayed-release capsules, a pancreatic enzyme product (PEP), has received ...
May 7, 2009 — Pancrelipase (Creon, Solvay Pharmaceuticals, Inc) delayed-release capsules were approved by the US Food and Drug Administration (FDA) for treatment of exocrine pancreatic insufficiency ...
ABBOTT PARK, Ill. — The Food and Drug Administration has approved a new dosage of a drug made by Abbott for treating cystic fibrosis in infants, the drug maker said Tuesday. Abbott announced the ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. CREON contains the active ingredient Pancreatic extract. CREON is used ...
Abbott gets US FDA nod for CREON infant-specific dosage for patients with EPI due to cystic fibrosis
Abbott announced that the US Food and Drug Administration (FDA) has approved an infant-specific dose of CREON (pancrelipase) delayed-release capsules to treat Exocrine Pancreatic Insufficiency (EPI) ...
PHARMACISTS are being forced to ration supplies of two life-saving medications for at least another month after major ...
NORTH CHICAGO, Ill., May 30, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that a new, higher-dose capsule of CREON ® (pancrelipase) Delayed-Release Capsules is commercially available in ...
John Swale, from Rotherham, says he is frightened by the thought of being without Creon A nationwide shortage of a drug designed to help people digest food is causing fear and frustration among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results